|
|
Volumn 28, Issue 30, 2010, Pages
|
|
Prognostic significance of molecular remission in follicular lymphoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYBRID PROTEIN;
IMMUNOGLOBULIN HEAVY CHAIN;
PROTEIN BCL 2;
RITUXIMAB;
ANTINEOPLASTIC AGENT;
BONE MARROW;
CANCER REGRESSION;
CANCER RELAPSE;
CHROMOSOME TRANSLOCATION 14;
FOLLICULAR LYMPHOMA;
GENE REARRANGEMENT;
HISTOPATHOLOGY;
HUMAN;
LETTER;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROGRESSION FREE SURVIVAL;
TUMOR CELL;
DISEASE FREE SURVIVAL;
DRUG RESISTANCE;
GENE EXPRESSION REGULATION;
GENE FUSION;
GENE TRANSLOCATION;
GENETICS;
IMMUNOGLOBULIN HEAVY CHAIN GENE;
MORTALITY;
NOTE;
RECURRENT DISEASE;
TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DISEASE-FREE SURVIVAL;
DRUG RESISTANCE, NEOPLASM;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE FUSION;
GENES, IMMUNOGLOBULIN HEAVY CHAIN;
HUMANS;
LYMPHOMA, FOLLICULAR;
POLYMERASE CHAIN REACTION;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RECURRENCE;
TIME FACTORS;
TRANSLOCATION, GENETIC;
TREATMENT OUTCOME;
|
|
EID: 78049499576
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2010.30.7280 Document Type: Letter |
|
Times cited : (2)
|
|
References (3)
|
